Literature DB >> 11945231

Pronuclear microinjection.

R J Wall1.   

Abstract

Last year marked the 20th anniversary of the invention of the term "transgenic" and the development of pronuclear microinjection, a straightforward technique designed to transfer genetic information from nearly any living organism to mammals. After two decades of use, pronuclear microinjection protocols have changed little from the reliable, if not efficient, method described by Gordon and Ruddle. Experience has taught us that once microinjection skills are perfected there are only a few parameters one needs to be concerned about to successfully produce transgenic animals. Those parameters will be discussed, as will some new innovations that promise to finally increase efficiency of pronuclear microinjection methodology.

Mesh:

Year:  2001        PMID: 11945231     DOI: 10.1089/15362300152725936

Source DB:  PubMed          Journal:  Cloning Stem Cells        ISSN: 1536-2302


  21 in total

1.  Efficient production by sperm-mediated gene transfer of human decay accelerating factor (hDAF) transgenic pigs for xenotransplantation.

Authors:  Marialuisa Lavitrano; Maria Laura Bacci; Monica Forni; Davide Lazzereschi; Carla Di Stefano; Daniela Fioretti; Paola Giancotti; Gabriella Marfé; Loredana Pucci; Luigina Renzi; Hongjun Wang; Antonella Stoppacciaro; Giorgio Stassi; Massimo Sargiacomo; Paola Sinibaldi; Valeria Turchi; Roberto Giovannoni; Giacinto Della Casa; Eraldo Seren; Giancarlo Rossi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-22       Impact factor: 11.205

2.  Increased efficiency of transgenic livestock production.

Authors:  Elizabeth A Maga; R Geoffrey Sargent; Hong Zeng; Sushma Pati; David A Zarling; Stefanie M Oppenheim; Nicole M B Collette; Alice L Moyer; Janice S Conrad-Brink; Joan D Rowe; Robert H BonDurant; Gary B Anderson; James D Murray
Journal:  Transgenic Res       Date:  2003-08       Impact factor: 2.788

3.  Nanoinjection: pronuclear DNA delivery using a charged lance.

Authors:  Quentin T Aten; Brian D Jensen; Susan Tamowski; Aubrey M Wilson; Larry L Howell; Sandra H Burnett
Journal:  Transgenic Res       Date:  2012-03-14       Impact factor: 2.788

Review 4.  Use of intracytoplasmic sperm injection (ICSI) to generate transgenic animals.

Authors:  Stefan Moisyadi; Joseph M Kaminski; Ryuzo Yanagimachi
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2008-08-08       Impact factor: 2.268

5.  Hyperactive self-inactivating piggyBac for transposase-enhanced pronuclear microinjection transgenesis.

Authors:  Joel Marh; Zoia Stoytcheva; Johann Urschitz; Atsushi Sugawara; Hideaki Yamashiro; Jesse B Owens; Ilko Stoytchev; Pawel Pelczar; Ryuzo Yanagimachi; Stefan Moisyadi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-23       Impact factor: 11.205

6.  Transgene delivery via intracellular electroporetic nanoinjection.

Authors:  Aubrey M Wilson; Quentin T Aten; Nathan C Toone; Justin L Black; Brian D Jensen; Susan Tamowski; Larry L Howell; Sandra H Burnett
Journal:  Transgenic Res       Date:  2013-03-27       Impact factor: 2.788

7.  Strain differences in superovulatory response, embryo development and efficiency of transgenic rat production.

Authors:  Elena Popova; Michael Bader; Alexander Krivokharchenko
Journal:  Transgenic Res       Date:  2005-10       Impact factor: 2.788

8.  Effects of AANAT overexpression on the inflammatory responses and autophagy activity in the cellular and transgenic animal levels.

Authors:  Jingli Tao; Minghui Yang; Hao Wu; Teng Ma; Changjiu He; Menglong Chai; Xiaosheng Zhang; Jinlong Zhang; Fangrong Ding; Sutian Wang; Shoulong Deng; Kuanfeng Zhu; Yukun Song; Pengyun Ji; Haijun Liu; Zhengxing Lian; Guoshi Liu
Journal:  Autophagy       Date:  2018-08-04       Impact factor: 16.016

Review 9.  Genetically modified pigs for biomedical research.

Authors:  Yonglun Luo; Lin Lin; Lars Bolund; Thomas G Jensen; Charlotte Brandt Sørensen
Journal:  J Inherit Metab Dis       Date:  2012-03-28       Impact factor: 4.982

10.  Efficient activation of reconstructed rat embryos by cyclin-dependent kinase inhibitors.

Authors:  Robin L Webb; Kirk A Findlay; Michael A Green; Tina L Beckett; M Paul Murphy
Journal:  PLoS One       Date:  2010-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.